Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Piper Sandler raised Supernus Pharmaceuticals Inc (NASDAQ:SUPN) price target from $40 to $65. Piper Sandler analyst David Amsellem upgraded the rating for the stock from Neutral to Overweight. Supernus Pharmaceuticals shares closed at $48.00 on Wednesday. See how other analysts view this stock.
  • Berenberg cut the price target for DraftKings Inc (NASDAQ:DKNG) from $45 to $43. Berenberg analyst Jack Cummins upgraded the stock from Hold to Buy. DraftKings shares closed at $33.98 on Wednesday. See how other analysts view this stock.
  • Piper Sandler boosted PNC Financial Services Group Inc (NYSE:PNC) price target from $211 to $220. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. PNC shares closed at $190.16 on Wednesday. See …

Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Piper Sandler raised Supernus Pharmaceuticals Inc (NASDAQ:SUPN) price target from $40 to $65. Piper Sandler analyst David Amsellem upgraded the rating for the stock from Neutral to Overweight. Supernus Pharmaceuticals shares closed at $48.00 on Wednesday. See how other analysts view this stock.
  • Berenberg cut the price target for DraftKings Inc (NASDAQ:DKNG) from $45 to $43. Berenberg analyst Jack Cummins upgraded the stock from Hold to Buy. DraftKings shares closed at $33.98 on Wednesday. See how other analysts view this stock.
  • Piper Sandler boosted PNC Financial Services Group Inc (NYSE:PNC) price target from $211 to $220. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. PNC shares closed at $190.16 on Wednesday. See …

Full story available on Benzinga.com

 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Piper Sandler raised Supernus Pharmaceuticals Inc (NASDAQ:SUPN) price target from $40 to $65. Piper Sandler analyst David Amsellem upgraded the rating for the stock from Neutral to Overweight. Supernus Pharmaceuticals shares closed at $48.00 on Wednesday. See how other analysts view this stock.
Berenberg cut the price target for DraftKings Inc (NASDAQ:DKNG) from $45 to $43. Berenberg analyst Jack Cummins upgraded the stock from Hold to Buy. DraftKings shares closed at $33.98 on Wednesday. See how other analysts view this stock.
Piper Sandler boosted PNC Financial Services Group Inc (NYSE:PNC) price target from $211 to $220. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. PNC shares closed at $190.16 on Wednesday. See …Full story available on Benzinga.com   Read Moreanalysts forecasts, BE, CFG, CRWD, DKNG, HOOD, KTOS, News, PNC, PT Changes, SF, SUPN, TSCO, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, KTOS, US50077B2079, TSCO, US8923561067, PNC, US6934751057, SF, US8606301021, SUPN, CFG, BE, CRWD, DKNG, HOOD, News, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets